1337 related articles for article (PubMed ID: 9265639)
1. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
2. Contribution of cysteine 158, the glycosylation site threonine 194, the amino- and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide beta (1-40).
Aleshkov SB; Li X; Lavrentiadou SN; Zannis VI
Biochemistry; 1999 Jul; 38(28):8918-25. PubMed ID: 10413465
[TBL] [Abstract][Full Text] [Related]
3. Association of human, rat, and rabbit apolipoprotein E with beta-amyloid.
LaDu MJ; Lukens JR; Reardon CA; Getz GS
J Neurosci Res; 1997 Jul; 49(1):9-18. PubMed ID: 9211985
[TBL] [Abstract][Full Text] [Related]
4. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide.
Stratman NC; Castle CK; Taylor BM; Epps DE; Melchior GW; Carter DB
Chem Phys Lipids; 2005 Oct; 137(1-2):52-61. PubMed ID: 16140289
[TBL] [Abstract][Full Text] [Related]
5. Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid.
Yamauchi K; Tozuka M; Nakabayashi T; Sugano M; Hidaka H; Kondo Y; Katsuyama T
J Neurosci Res; 1999 Oct; 58(2):301-7. PubMed ID: 10502286
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
Baum L; Chen L; Ng HK; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
[TBL] [Abstract][Full Text] [Related]
7. Isoform-specific effect of apolipoprotein E on endocytosis of beta-amyloid in cultures of neuroblastoma cells.
Yamauchi K; Tozuka M; Hidaka H; Nakabayashi T; Sugano M; Katsuyama T
Ann Clin Lab Sci; 2002; 32(1):65-74. PubMed ID: 11848621
[TBL] [Abstract][Full Text] [Related]
8. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42.
Trommer BL; Shah C; Yun SH; Gamkrelidze G; Pasternak ES; Stine WB; Manelli A; Sullivan P; Pasternak JF; LaDu MJ
Neurobiol Dis; 2005 Feb; 18(1):75-82. PubMed ID: 15649697
[TBL] [Abstract][Full Text] [Related]
9. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins.
Fleming LM; Weisgraber KH; Strittmatter WJ; Troncoso JC; Johnson GV
Exp Neurol; 1996 Apr; 138(2):252-60. PubMed ID: 8620924
[TBL] [Abstract][Full Text] [Related]
10. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction.
Wang H; Durham L; Dawson H; Song P; Warner DS; Sullivan PM; Vitek MP; Laskowitz DT
Neuroscience; 2007 Feb; 144(4):1324-33. PubMed ID: 17187933
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein-E modulates the cytotoxic effect of beta-amyloid on rat brain endothelium in an isoform-dependent specific manner.
Folin M; Baiguera S; Guidolin D; Di Liddo R; Grandi C; De Carlo E; Nussdorfer GG; Parnigotto PP
Int J Mol Med; 2006 May; 17(5):821-6. PubMed ID: 16596266
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
13. The structure of human apolipoprotein E2, E3 and E4 in solution. 2. Multidomain organization correlates with the stability of apoE structure.
Clément-Collin V; Barbier A; Dergunov AD; Visvikis A; Siest G; Desmadril M; Takahashi M; Aggerbeck LP
Biophys Chem; 2006 Jan; 119(2):170-85. PubMed ID: 16125836
[TBL] [Abstract][Full Text] [Related]
14. Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes.
Rapp A; Gmeiner B; Hüttinger M
Biochimie; 2006 May; 88(5):473-83. PubMed ID: 16376010
[TBL] [Abstract][Full Text] [Related]
15. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease.
Fagan AM; Watson M; Parsadanian M; Bales KR; Paul SM; Holtzman DM
Neurobiol Dis; 2002 Apr; 9(3):305-18. PubMed ID: 11950276
[TBL] [Abstract][Full Text] [Related]
16. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
Dolev I; Michaelson DM
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
Fagan AM; Holtzman DM
Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
Richey PL; Siedlak SL; Smith MA; Perry G
Biochem Biophys Res Commun; 1995 Mar; 208(2):657-63. PubMed ID: 7695621
[TBL] [Abstract][Full Text] [Related]
19. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
Dodart JC; Marr RA; Koistinaho M; Gregersen BM; Malkani S; Verma IM; Paul SM
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1211-6. PubMed ID: 15657137
[TBL] [Abstract][Full Text] [Related]
20. Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes.
Ito S; Ohtsuki S; Kamiie J; Nezu Y; Terasaki T
J Neurochem; 2007 Dec; 103(6):2482-90. PubMed ID: 17908238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]